13:30-13:50 | TBD
Hannah Ennerfelt (Stanford University – Stanford, CA, USA)
13:50-14:10 | Role of Innate Immune Dysfunction in Alzheimer’s Disease
John R. Lukens (University of Virginia, Center for Brain Immunology and Glia (BIG) – Charlottesville, VA, USA)
14:10-14:30 | Amyloid-β aggregates are Important Targets of a Disease-Modifying Approach for Alzheimer’s Disease
Kenjiro Ono (Kanazawa University Graduate School of Medical Sciences – Kanazawa, Japan)
14:30-14:50 | O-91 | Chronic stress attenuates CNS myeloid cell function and neurotoxicity in Alzheimer’s disease
Yoel Shor (The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center – Jerusalem, Israel)